Sign Up Today and Learn More About Bota Biosciences Stock
Invest in or calculate the value of your shares in Bota Biosciences or other pre-IPO companies through EquityZen's platform.
Bota Biosciences Stock
Bota is an industrial synthetic biotechnology company with a vision to program biological systems for clean and efficient bio-manufacturing.
About Bota Biosciences Stock
Founded
2019
Industries
Manufacturing, Science and Engineering, Biotechnology
Bota Biosciences (Bota Bio) is a global industrial biotechnology company connecting biological design to scale-up manufacturing to accelerate shifts to sustainable living. Bota has built an integrative bioengineering platform, to develop and implement efficient, eco-friendly, and cost-effective biomanufacturing technologies. Committed to its mission, Bota established its own pilot plant and manufacturing facility, affirming its dedication to offering scalable industrial solutions and market-ready products. This infrastructure strengthens support for customers and partners across industries such as nutrition, food, personal care, and animal health. Powered by a dynamic, multidisciplinary team, Bota Bio channels biotech innovations to create a global impact. The company's Series B financing has surpassed $100 million, bringing its aggregate funding to $145 million, with investment from notable strategic and financial investors, including Hong Shan Capital, Matrix Partners, and BASF Ventures.
Bota Biosciences Press Mentions
Stay in the know about the latest news on Bota Biosciences
Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established
prnewswire • Jun 25, 2024
Synthetic Biology Market to Surpass USD 52.6 Billion by 2030 due to Rapid Advancements in Genetic Engineering and ...
finance • May 05, 2024
Government Funding Propels Global Synthetic Biology Market ...
globenewswire • Jan 29, 2024
Government Funding Propels Global Synthetic Biology Market ...
finance • Dec 20, 2023
Sequoia China leads $100m Series B for Bota Biosciences
avcj • Jul 30, 2021
Bota Biosciences Management
Leadership team at Bota Biosciences
Co-founder and CEO
Cheryl Cui
Join now and verify your accreditation status to gain access to:
- Bota Biosciences Current Valuation
- Bota Biosciences Stock Price
- Bota Biosciences Management
- Available deals in Bota Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Bota Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Bota Biosciences Revenue and Financials
- Bota Biosciences Highlights
- Bota Biosciences Business Model
- Bota Biosciences Risk Factors
- Bota Biosciences Research Report from SACRA Research
Trading Bota Biosciences Stock
How to invest in Bota Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Bota Biosciences through EquityZen funds. These investments are made available by existing Bota Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Bota Biosciences stock?
Shareholders can sell their Bota Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 390K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."